<DOC>
	<DOCNO>NCT00263016</DOCNO>
	<brief_summary>Primary Objective : - To compare tumour response rate combination chemotherapy irinotecan/cisplatin ( IC ) versus docetaxel/cisplatin ( DC ) advance NSCLC patient respond 3 course docetaxel/cisplatin . Secondary Objectives : - To compare time progression chemotherapy treatment IC DC arm treatment . - To compare toxicity profile IC DC arm treatment .</brief_summary>
	<brief_title>Docetaxel Non Small Cell Lung Cancer ( NSCLC )</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<criteria>Histologically cytologically proven nonsmall cell lung carcinoma first diagnosis . Stage IIIB IV disease . Tumour consider unresectable . Performance status Karnofsky index &gt; 60 % WHO performance status &lt; = 1 . Previous therapy Chemotherapy : None . Previous radiation therapy : prior irradiation NSCLC permit , however , measurable evaluable nonmeasurable disease must completely outside radiation portal . Laboratory requirement : Hematology : Neutrophils ≥ 2.0 10^9/l , Platelets ≥ 100 10^9/l , Hemoglobin ≥ 10 g/dl . Hepatic function : Total bilirubin &lt; 1 Upper Normal Limit ( UNL ) , AST ( SGOT ) ALT ( SGPT ) &lt; 2.5 UNL , Alkaline phosphatase &lt; 5 UNL ; except presence bone metastasis absence liver disorder . Patients AST and/or ALT &gt; 1.5 x UNL associate alkaline phosphatase &gt; 2.5 x UNL eligible study . Renal function : Creatinine &lt; 140 µmol/l ( 1.6 mg/dl ) ; limit value , calculate creatinine clearance &gt; 60 ml/min . Pregnant , lactate patient ; patient childbearing potential must implement adequate contraceptive measure study participation . Known clinical brain leptomeningeal involvement . Preexisting motor sensory neurotoxicity severity &gt; grade 1 National Cancer Institute criterion . Other serious illness medical condition : Congestive heart failure unstable angina pectoris even medically control . Previous history myocardial infarction within 1 year study entry , uncontrolled hypertension high risk uncontrolled arrhythmia . History significant neurologic psychiatric disorder include psychotic disorder , dementia seizure would prohibit understanding give informed consent . Active uncontrolled infection . Peptic ulcer , unstable diabetes mellitus contraindication use corticosteroid . Past current history neoplasm nonsmall cell lung cancer , except curatively treat nonmelanoma skin cancer , situ carcinoma cervix . Concurrent treatment prednisone ( equivalent ) except use prophylactic medication regimen , treatment acute hypersensitivity reaction , treatment nausea / vomit unless chronic treatment ( initiate &gt; 6 month prior study entry ) low dose ( &lt; 20 mg methylprednisolone equivalent ) . Definite contraindication use corticosteroid . Concurrent treatment experimental drug . Participation another clinical trial investigational drug within 30 day prior study entry . Concurrent treatment anticancer therapy . The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2008</verification_date>
</DOC>